GB9703103D0 - Protein - Google Patents

Protein

Info

Publication number
GB9703103D0
GB9703103D0 GBGB9703103.3A GB9703103A GB9703103D0 GB 9703103 D0 GB9703103 D0 GB 9703103D0 GB 9703103 A GB9703103 A GB 9703103A GB 9703103 D0 GB9703103 D0 GB 9703103D0
Authority
GB
United Kingdom
Prior art keywords
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9703103.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Priority to GBGB9703103.3A priority Critical patent/GB9703103D0/en
Publication of GB9703103D0 publication Critical patent/GB9703103D0/en
Priority to GBGB9707599.8A priority patent/GB9707599D0/en
Priority to AU26455/97A priority patent/AU719513B2/en
Priority to US09/171,945 priority patent/US6277599B1/en
Priority to PCT/GB1997/001165 priority patent/WO1997042329A1/en
Priority to PL97329871A priority patent/PL329871A1/en
Priority to CA002250579A priority patent/CA2250579A1/en
Priority to EP97918258A priority patent/EP0896626B1/en
Priority to TR1998/02227T priority patent/TR199802227T2/en
Priority to CZ983536A priority patent/CZ353698A3/en
Priority to HU9901562A priority patent/HUP9901562A3/en
Priority to JP09539625A priority patent/JP2000510692A/en
Priority to ES97918258T priority patent/ES2279539T3/en
Priority to DE69737188T priority patent/DE69737188T2/en
Priority to IL12677297A priority patent/IL126772A0/en
Priority to CN97194390A priority patent/CN1217750A/en
Priority to AT97918258T priority patent/ATE350478T1/en
Priority to SK1502-98A priority patent/SK150298A3/en
Priority to BR9708910A priority patent/BR9708910A/en
Priority to NZ331978A priority patent/NZ331978A/en
Priority to NO985120A priority patent/NO985120L/en
Priority to US09/910,059 priority patent/US6903203B2/en
Pending legal-status Critical Current

Links

GBGB9703103.3A 1996-05-04 1997-02-14 Protein Pending GB9703103D0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
GBGB9703103.3A GB9703103D0 (en) 1997-02-14 1997-02-14 Protein
GBGB9707599.8A GB9707599D0 (en) 1996-05-04 1997-04-15 Proteins
NZ331978A NZ331978A (en) 1996-05-04 1997-04-29 Monoclonal antibody to CEA (carcinomembryonic antigen), conjugates comprising said antibody, and their therapeutic use in an adept system
HU9901562A HUP9901562A3 (en) 1996-05-04 1997-04-29 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
DE69737188T DE69737188T2 (en) 1996-05-04 1997-04-29 MONOCLONAL ANTIBODY AGAINST CEA, CONJUGATES CONTAINING THIS ANTIBODY AND THEIR THERAPEUTIC USE IN AN ADEPT SYSTEM
PCT/GB1997/001165 WO1997042329A1 (en) 1996-05-04 1997-04-29 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
PL97329871A PL329871A1 (en) 1996-05-04 1997-04-29 Monoclonal antibody agains cea, coniugates incorporating that antibody and their therapeutic application in the adept system
CA002250579A CA2250579A1 (en) 1996-05-04 1997-04-29 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
EP97918258A EP0896626B1 (en) 1996-05-04 1997-04-29 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
TR1998/02227T TR199802227T2 (en) 1996-05-04 1997-04-29 Monoclonal antibody against CEA, conjugates containing said antibody and their therapeutic use in an ADEPT system.
CZ983536A CZ353698A3 (en) 1996-05-04 1997-04-29 Monoclonal antibody against cea, conjugates in which it is comprised, process of their preparation and pharmaceutical composition containing thereof
AU26455/97A AU719513B2 (en) 1996-05-04 1997-04-29 Monoclonal antibody to CEA, conjugates comprising said antibody, and their therapeutic use in an adept system
JP09539625A JP2000510692A (en) 1996-05-04 1997-04-29 Monoclonal antibodies to CEA, conjugates comprising the antibodies, and their therapeutic use in ADEPT systems
ES97918258T ES2279539T3 (en) 1996-05-04 1997-04-29 ANTI-CEA MONOCLONAL ANTIBODY, CONJUGATES UNDERSTANDING ANTIBODY, AND THERAPEUTIC USE IN AN ADEPT SYSTEM.
US09/171,945 US6277599B1 (en) 1996-05-04 1997-04-29 Anti-CEA antibody designated 806.077, hybridoma and method of manufacture
IL12677297A IL126772A0 (en) 1996-05-04 1997-04-29 Monoclonal antibody of cea conjugates comprising said antibody and their therapeutic use in an adept system
CN97194390A CN1217750A (en) 1996-05-04 1997-04-29 Monoclonal antibody to CEA, Conjugates comprising said antibody, and their therapeutic use in ADEPT system
AT97918258T ATE350478T1 (en) 1996-05-04 1997-04-29 MONOCLONAL ANTIBODIES TO CEA, CONJUGATES CONTAINING THIS ANTIBODIES AND THEIR THERAPEUTIC USE IN AN ADEPT SYSTEM
SK1502-98A SK150298A3 (en) 1996-05-04 1997-04-29 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
BR9708910A BR9708910A (en) 1996-05-04 1997-04-29 Conjugated antibody polynucleotide sequence vector host cell hybridoma pharmaceutical composition processes for making an antibody or conjugate and for treating a human or animal in need of this treatment
NO985120A NO985120L (en) 1996-05-04 1998-11-03 Monoclonal antibody to CEA, conjugates comprising said antibody and their therapeutic deployment in an ADEPT system
US09/910,059 US6903203B2 (en) 1996-05-04 2001-07-23 Monoclonal antibody to CEA, conjugates comprising said antibody and their therapeutic use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9703103.3A GB9703103D0 (en) 1997-02-14 1997-02-14 Protein

Publications (1)

Publication Number Publication Date
GB9703103D0 true GB9703103D0 (en) 1997-04-02

Family

ID=10807676

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9703103.3A Pending GB9703103D0 (en) 1996-05-04 1997-02-14 Protein

Country Status (1)

Country Link
GB (1) GB9703103D0 (en)

Similar Documents

Publication Publication Date Title
ZA9710338B (en) Proteins
GB9719879D0 (en) Protein
GB9703681D0 (en) Protein complemention
EP1018551A4 (en) Megsin protein
PL344979A1 (en) Angiostatin-binding protein
ZA984322B (en) Sucrose-binding proteins
GB9715064D0 (en) Protein expression
GB9828704D0 (en) Proteins
GB9816337D0 (en) Proteins
GB9720784D0 (en) Protein
GB9828880D0 (en) Protein
GB9819038D0 (en) Protein
GB9809566D0 (en) Protein
GB9812607D0 (en) Protein
EP0915100A4 (en) Novel protein
GB9720785D0 (en) Protein
GB9719670D0 (en) Protein
GB9703103D0 (en) Protein
GB9604865D0 (en) Modified proteins
GB0315759D0 (en) Proteins
GB9816335D0 (en) Proteins
GB9816336D0 (en) Proteins
GB9722003D0 (en) Proteins
GB9707822D0 (en) Proteins
GB9707499D0 (en) Proteins